Movement Alert｜Ping An Good Doctor Rises 5.26% in Regular Trading, Partners with Pfizer China to Build Medical-Pharmaceutical-Insurance Integrated Dual Closed-Loop

Market Focus07-08

On July 8, Ping An Good Doctor (01833.HK) rose 5.26% in regular trading, trading at HK$7.59/share, with turnover of approximately HK$75.66 million.

On the news front, the company announced on July 7 a deep strategic cooperation with Pfizer China. Leveraging Ping An's medical and health services, commercial insurance payment capabilities, enterprise health management, AI medical technology, and its user base of over 100 million, combined with Pfizer's strengths in innovative drug R&D and evidence-based medicine, the two parties will jointly build a dual closed-loop system encompassing a commercial closed-loop for medical-pharmaceutical-insurance integration and a full disease-course management closed-loop. CEO He Mingke stated that deep integration of medicine, pharmaceuticals, and insurance represents a core development direction for internet healthcare.

On fundamentals, the company reported Q1 revenue of RMB 1.159 billion, up 9.1% year-over-year, with adjusted net profit of RMB 84.4 million, up 45.8%. CICC initiated coverage with an Outperform rating and a target price of HK$14.20.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1150815367?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-08 14:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150815367","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Ping An Good Doctor Rises 5.26% in Regular Trading, Partners with Pfizer China to Build Medical-Pharmaceutical-Insurance Integrated Dual Closed-Loop","media":"Market Focus","content":"<p><p>On July 8, Ping An Good Doctor (01833.HK) rose 5.26% in regular trading, trading at HK$7.59/share, with turnover of approximately HK$75.66 million.</p><p>On the news front, the company announced on July 7 a deep strategic cooperation with Pfizer China. Leveraging Ping An's medical and health services, commercial insurance payment capabilities, enterprise health management, AI medical technology, and its user base of over 100 million, combined with Pfizer's strengths in innovative drug R&D and evidence-based medicine, the two parties will jointly build a dual closed-loop system encompassing a commercial closed-loop for medical-pharmaceutical-insurance integration and a full disease-course management closed-loop. CEO He Mingke stated that deep integration of medicine, pharmaceuticals, and insurance represents a core development direction for internet healthcare.</p><p>On fundamentals, the company reported Q1 revenue of RMB 1.159 billion, up 9.1% year-over-year, with adjusted net profit of RMB 84.4 million, up 45.8%. CICC initiated coverage with an Outperform rating and a target price of HK$14.20.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Ping An Good Doctor Rises 5.26% in Regular Trading, Partners with Pfizer China to Build Medical-Pharmaceutical-Insurance Integrated Dual Closed-Loop</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Ping An Good Doctor Rises 5.26% in Regular Trading, Partners with Pfizer China to Build Medical-Pharmaceutical-Insurance Integrated Dual Closed-Loop\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-08 14:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 8, Ping An Good Doctor (01833.HK) rose 5.26% in regular trading, trading at HK$7.59/share, with turnover of approximately HK$75.66 million.</p><p>On the news front, the company announced on July 7 a deep strategic cooperation with Pfizer China. Leveraging Ping An's medical and health services, commercial insurance payment capabilities, enterprise health management, AI medical technology, and its user base of over 100 million, combined with Pfizer's strengths in innovative drug R&D and evidence-based medicine, the two parties will jointly build a dual closed-loop system encompassing a commercial closed-loop for medical-pharmaceutical-insurance integration and a full disease-course management closed-loop. CEO He Mingke stated that deep integration of medicine, pharmaceuticals, and insurance represents a core development direction for internet healthcare.</p><p>On fundamentals, the company reported Q1 revenue of RMB 1.159 billion, up 9.1% year-over-year, with adjusted net profit of RMB 84.4 million, up 45.8%. CICC initiated coverage with an Outperform rating and a target price of HK$14.20.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01833","symbol_name":"平安好医生","start_time":0,"source_url":"","article_id":"1150815367","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150815367","pubTimestamp":1783490669,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 8, Ping An Good Doctor (01833.HK) rose 5.26% in regular trading, trading at HK$7.59/share, with turnover of approximately HK$75.66 million.On the news front, the company announced on July 7 a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01833":"平安好医生"},"translate_title":"动感快讯|平安好医生常规交易涨5.26%携手辉瑞中国构建医-药-险一体化双闭环","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01833":1},"content_text":"On July 8, Ping An Good Doctor (01833.HK) rose 5.26% in regular trading, trading at HK$7.59/share, with turnover of approximately HK$75.66 million.On the news front, the company announced on July 7 a deep strategic cooperation with Pfizer China. Leveraging Ping An's medical and health services, commercial insurance payment capabilities, enterprise health management, AI medical technology, and its user base of over 100 million, combined with Pfizer's strengths in innovative drug R&D and evidence-based medicine, the two parties will jointly build a dual closed-loop system encompassing a commercial closed-loop for medical-pharmaceutical-insurance integration and a full disease-course management closed-loop. CEO He Mingke stated that deep integration of medicine, pharmaceuticals, and insurance represents a core development direction for internet healthcare.On fundamentals, the company reported Q1 revenue of RMB 1.159 billion, up 9.1% year-over-year, with adjusted net profit of RMB 84.4 million, up 45.8%. CICC initiated coverage with an Outperform rating and a target price of HK$14.20.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1150815367","isCrawlerRequest":true}